FIGS Soars 6% on Oppenheimer’s Higher $25 Price Target Ahead of Earnings
FIGS stock rose 6% after Oppenheimer raised its price target to $25, citing strong growth expectations. Analysts project EPS to nearly double in 2026, but only 6% growth in 2027. The company reports Q3 earnings on Nov. 5, with guidance for 20% revenue growth.
How this was made
The 30-second read
Why it matters
The analyst upgrade and higher price target provide a catalyst for short‑term buying, but longer‑term concerns may limit upside.
Market read
The news creates immediate bullish pressure on FIGS ahead of earnings, with potential for short‑term trade ideas.
What to watch
Potential margin pressure from the recent customs order and a slower growth outlook for 2027.
Background
FIGS is a digital‑health apparel company that has surged over 80% this year. Analysts expect near‑term earnings growth but warn of slower growth in 2027 and a customs‑order supply risk.
Ticker impact
Oppenheimer raised its price target to $25 and upgraded FIGS to Outperform, prompting a 6% share jump ahead of the upcoming earnings report.
upward pressure as investors price in the new target and rating
The upgrade is fresh, the target increase is material, and the stock already moved 6% on the news.
Market effects
Positive signal for the digital health sector as a peer receives a higher target.
Limited to U.S. equity markets; no broader regional effect.
Minor global relevance; primarily impacts U.S. investors.
Counterpoint
The upgrade may be premature given modest 2027 growth expectations and supply‑chain risks.
Key entities
- AnalystOppenheimer
Raised FIGS price target to $25 and upgraded rating to Outperform.
- CompanyFIGS
Digital‑health apparel firm reporting Q3 results on Nov 5.
